Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Leading Joint Health Product, Arthro-7® From U.S. Doctors’ Clinical® Hits The Shelves At Leading Retail Outlets
  • USA - English


News provided by

Knack Media

Feb 25, 2015, 03:00 ET

Share this article

Share toX

Share this article

Share toX

Youtube
Youtube

Positive Results Seen in as Little as 2 Weeks ✔ Try Risk Free, 1 Year Money Back Guarantee

Post this

(PRWEB) February 25, 2015 -- For over 20 years, Arthro-7® has been a jewel of a little secret to those with joint health concerns. Over 8 million units have sold through television, online marketing, and direct market sales, will now be widely available in leading retail stores. But it has never before been widely available in leading retail stores. Despite this, it has achieved great popularity in nutritional supplement circles through positive word-of-mouth and testimonials from loyal customers who have recommended it to family and friends. This premium nutritional supplement is one of the few formulas that is doctor formulated and recommended in the offices of many private practitioners. Due to overwhelming customer demand, U.S. Doctors’ Clinical® is looking to expand the availability of this supplement into some of the nation’s leading retail stores and pharmacies.

The formulators of Arthro-7® saw the need for a joint health supplement that was not glucosamine or chondroitin based due to the allergic reactions these shellfish-based ingredients may induce. The ingredients in this formula were carefully selected based on their individual merits and abilities to support joint discomfort. Together, the results are even more impressive.

Arthro-7® combines 7 ingredients (Vitamin C, Collagen, MSM, CMO, Turmeric, Bromelain, and Lipase) into a single complex supplement that can be taken daily to relieve discomfort, promote mobility, rejuvenate tissue, and nourish cartilage. To validate Arthro-7®’s effectiveness, it was subjected to a 12-week, double-blind, placebo-controlled clinical trial. This study was published in the peer-reviewed scientific journal, Nutrition and Dietary Supplements.

Within just 2 weeks, many of the volunteers in the Arthro-7® group experienced positive changes to their joint health. Additional self-reported changes were recorded at weeks 4, 8, and 12 (the end of the study period). Compared to the placebo, 74.5% of Arthro-7® users reported improvements to their joint symptom scores. Overall, researchers concluded that Arthro-7® showed potent effects at relieving symptoms such as joint discomfort and joint stiffness, and helped improve mobility in patients.

Arthro-7®’s unique formulation, as well as its competitive price point, will help open consumer eyes to the fact that it is a much superior product compared to other joint health supplements currently available. While similar products may contain clinically tested ingredients, Arthro-7® is one of the few clinically proven products verified as a whole formula. Furthermore, besides being shellfish free, Arthro-7® is also gluten free and is a proud sponsor of the Arthritis Foundation, a non-profit organization dedicated to joint health research.

In addition to Arthro-7®, U.S. Doctors’ Clinical® offers a premium range of clinically proven, doctor-formulated products containing high-quality nutrients that deliver the most potent benefits across numerous health categories such as: Antioxidants & Vitality, Cholesterol Support, Digestive Health, Prostate Health, and more. Combined, the entire U.S. Doctors’ Clinical® line has sold over 20 million products. These formulas are made to the exacting standards of professional doctors and other healthcare practitioners. This is largely because many of these supplements are created with the input of medical doctors, naturopathic doctors, chiropractors, and other members of the U.S. Doctors’ Clinical® advisory board, which currently consists of over 40 healthcare professionals.

The “Clinical” part of the brand name stems from the fact that these top-of-the-line formulas have been developed to withstand the rigors of human clinical trials. Many of the leading U.S. Doctors’ Clinical® formulas are clinically proven to be effective, and U.S. Doctors’ Clinical® is currently in the process of putting its entire product line through clinical trials to prove their efficacies.

Every U.S. Doctors’ Clinical® supplement is manufactured in a state-of-the-art, FDA-registered facility in Southern California. This manufacturing facility holds more third-party certifications for Good Manufacturing Practices (GMP) compliance than any other supplement maker in the United States. Premium-grade ingredients are sourced from around the world, but every product is created, packaged, and sealed in the USA to ensure that customers are getting maximum purity and effectiveness. These nutritional supplements are optimized to provide the greatest health benefits possible to not only help manage any existing health conditions, but take preemptive measures against changes that can develop with age. Many U.S. Doctors’ Clinical® customers faithfully reorder their supplements to maintain the positive changes they have reported to their health and well-being from using these unique dietary supplements.

Unlike many other premium brands, U.S. Doctors’ Clinical® backs up all its products with an extended 1-year, full money-back guarantee on all purchases. This speaks volumes of the confidence and quality that goes into creating these unique nutraceuticals. If a customer is not happy with the quality of any of their products, U.S. Doctors’ Clinical® will honor any refund for the unused portion of the formula.

U.S. Doctors’ Clinical® looks forward to introducing its entire product line into retail stores so that consumers across the country can experience, firsthand, the benefits of these premium-range nutraceutical formulas. For further information about the U.S. Doctors’ Clinical® product line, please go to http://www.usdoctorsclinical.com, and look for Arthro-7® in a retail location

Mason Baxter, Knack Media, http://www.knackmedia.com, +1 (877) 957-2244, [email protected]

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.